top of page

Kansas Democratic lawmakers are renewing their call to legalize medical marijuana in the state after police raided the hospital room of a terminally ill cancer patient over possession of cannabis extracts.

Just days before Christmas, officers in Hays, Kansas allegedly visited the patient’s room and confiscated a marijuana vaping device and cannabis extract.

The news of the law enforcement action against the 69-year-old man, Greg Bretz, ignited a strong response from the cannabis reform community. He told The Wichita Eagle that he was using cannabis to relief symptoms of his condition while spending weeks “flat on my back” since being hospitalized three weeks ago.

A doctor, Bretz said, told him to use whatever means necessary to ameliorate the pain. But hospital staff contacted law enforcement after he allegedly vaped in his hospital room, and three officers then paid him a visit. They seized his vape device as well as edible paste containing THC.

Staff at the Hays Medical Center reportedly said they were worried that the vaping device could be a potential fire hazard—though Bretz said he was not on oxygen, raising questions about the concern.

The end result, however, is a terminally ill man facing possible prosecution over the possessing cannabis that he says us used medically.

And Kansas House Democrats were quick to amplify the story to demonstrate the need to enact a policy change in the state.

House Dems are committed to legalizing access to medical marijuana. #MMJ is available to ill patients in dozens of states across the country.

Kansans shouldn’t be forced to choose between quality, safe health care and abiding by the law. #ksleghttps://t.co/RhVDMJY5mz

— Kansas House Democrats (@KSHouseDems) December 26, 2022


“House Dems are committed to legalizing access to medical marijuana. [Medical marijuana] is available to ill patients in dozens of states across the country,” the party wrote on Monday. “Kansans shouldn’t be forced to choose between quality, safe health care and abiding by the law.”

Bretz was initially given a ticket to appear in court for an appearance on January 2, but The Salina Post reported that it was later dismissed by more senior police officials.

Hays Police Chief Don Scheibler said that the officers involved “weren’t perfect that day” but he defended their overall performance, saying that current laws put them “in a very difficult position.”

“We want to say this is a law but don’t enforce it,” he said, noting shifting public attitudes about cannabis policy. “That’s gonna be a challenge for us.”

“It’s important that we have these discussions,” Scheibler said. “It’s important that we have clear laws for law enforcement to enforce. And we need to do what we think is best for all of Kansas. Again, the only thing I’m sorry about that day was that man’s got to deal with one of the most private things in his life. And that’s no longer possible now. For that, I’m sorry.”

In any case, Bretz’s story is reminiscent of a 2019 controversy that saw three Missouri police officers visit a hospital and search through the belongings of a man with stage-four pancreatic cancer in a fruitless attempt to find marijuana.

Missouri, which is right next door to Kansas, has since legalized cannabis for adult use following last month’s ballot initiative vote on the reform.

Kansas, meanwhile, remains one of a declining number few states that have kept prohibition on the books even for medical use of cannabis.

The Kansas House of Representatives approved a medical marijuana bill in the last session, but it later stalled in the Senate.

Supportive lawmakers are hoping to see a policy change in the upcoming session. Members of a special committee held a final meeting on medical marijuana issues this month that will be used to inform reform legislation that will be introduced in the 2023 session.

The Special Committee on Medical Marijuana, members of which toured a Missouri cannabis cultivation facility this month as part of their work, went over the wide range of issues that they’ve been discussing with officials and experts in recent months. The plan is to finalize a report with recommendations for the legislature heading into the new year.

At an earlier hearing in October, members focused on the “public policy implications” of the reform, receiving testimony from stakeholders and advocates about how to effectively regulate the market, touching on issues like track-and-trace, the pros and cons of licensing caps and the role that physicians should play.

The bicameral committee, which was formed in Juneconvened for an initial meeting in October that involved state officials, law enforcement and an Oklahoma medical cannabis regulator giving their perspective on the issue.

In the midst of these discussions, a spokesperson for the top Kansas GOP senator recently said the issue is “not a priority”—prompting pushback from House Democratic leadership.

The spokesperson said that Senate President Ty Masterson (R) recognizes that the reform issue is “maturing,” adding that any federal action “would be more evidence of that.” However, “it is not a priority” for the senator, who wields significant influence over what legislation advances.

While advocates were disappointed that lawmakers were unable to pass a medical cannabis bill by the end of the 2022 session in May—despite considerable momentum and the support of Gov. Laura Kelly (D)—the hope is that the committee’s work will lay the groundwork for meaningful action when the legislature convenes again.

The special panel is comprised of members appointed by the House speaker and Senate president.

House Minority Leader Tom Sawyer (D) said in June that he’s “been pretty frustrated that we have yet to get a bill passed,” while acknowledging that the House voted to legalize medical marijuana last year only to see a relative lack of action in the Senate.

The Senate did hold several hearings on cannabis reform this year, but members never got around to scheduling a vote. Late in the session, legislative leaders formed a bicameral conference committee that was tasked with arriving at a deal that could pass both chambers, although that didn’t pan out by the time lawmakers adjourned.

Democratic lawmakers made a final push to enact medical cannabis legalization before the legislative deadline, but Olson said in May that the “heavy load” his committee had to carry on other issues meant that lawmakers would not be “getting this measure across the finish line this session.”

Members of the House and Senate Federal and State Affairs Committees held two public conference meetings in April to discuss a way to merge the House-passed medical marijuana bill with a separate one that Senate lawmakers began considering this year. At the last official meeting, lawmakers from the House side went through areas where they were willing to concede to differences in the other chamber’s bill, as well as provisions they wanted to keep from their own measure.

Sawyer and Assistant Minority Leader Jason Probst (D) said in January that they wanted to let voters decide on legalizing medical and adult-use marijuana in the state.

The governor, for her part, wants to see medical cannabis legalization enacted, and she said earlier this year that she “absolutely” thinks the bill could pass if “everything else doesn’t take up all the oxygen.”

She previously pushed a separate proposal that would legalize medical cannabis and use the resulting revenue to support Medicaid expansion, with Rep. Brandon Woodard (D) filing the measure on the governor’s behalf.

Kelly has she said she wants voters to put pressure on their representatives to get the reform passed.

Following President Joe Biden’s announcement on pardoning people who’ve committed federal marijuana possession offenses and imploring governors to follow suit, Kelly said that her administration is “focused on legalizing medical marijuana so that Kansans with severe illnesses no longer have to suffer.

She added that they will “continue to consider all clemency and pardon requests based on a complete and thorough review of the individual cases.”

The governor also said in 2020 that while she wouldn’t personally advocate for adult-use legalization, she wouldn’t rule out signing the reform into law if a reform bill arrived on her desk.

Bipartisan Congressional Lawmakers Tout 2022 Marijuana Reform Accomplishments, Predict ‘Further Progress’ Next Session

Photo courtesy of Brian Shamblen.

 
 
 

The effort to legalize medical marijuana in Kansas is effectively dead for 2022, with a key Senate chairman conceding on Monday that reform will have to wait until next year to pass—but also saying that lawmakers will work over the summer to prepare a “near complete product” of a bill that can be considered when the legislature reconvenes early next year.

Monday marked the end of the legislative session. And while Democratic lawmakers made a final push to enact medical cannabis legalization before the deadline, Senate Federal and State Affairs Committee Chairman Robert Olson (R) said in a press release that the “heavy load” his committee had to carry on other issues means that lawmakers will not be “getting this measure across the finish line this session.”

“I am proud of what has been accomplished since the beginning of the session, but not convinced that we have been able to fully take into account the complexities presented by all the potential patients, experts (medical, law enforcement, industry, etc.) and agencies that will be responsible to regulate the recommendation, cultivation, production, distribution and safe consumption of substances that come from the cannabis plant,” Olson said.

This represents a significant setback for advocates and stakeholders. A medical cannabis bill already cleared the House of Representatives last year, and a bicameral conference committee met last month to discuss a potential deal to get the measure to the governor’s desk, but negotiations ultimately proved unfruitful.

What this means is that the legislative effort to get Kansas in line with the vast majorities of states with respect to medical cannabis policy will likely be on hold until 2023.

Olson said the he wants to “highly commend” his House committee counterpart Rep. John Barker (R) for his “energy and foresight to advance this effort and look forward to doing substantial summer interim work…with the primary objective of beginning the 2023 Legislative Session with a near complete product ready to submit to both chambers for consideration and approval.”

Marijuana Moment is already tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

Members of the House and Senate Federal and State Affairs Committees held two public meetings last month to discuss a way to merge the House-passed medical marijuana bill with a separate one that Senate lawmakers began considering this year. At the last official meeting, lawmakers from the House side went through areas where they were willing to concede to differences in the other chamber’s bill, as well as provisions they wanted to keep from their own measure.

In general, the two chambers’ proposals were already fairly similar, sharing numerous key provisions.

But to get closer to consensus, Barker said the body was willing to accept about a dozen elements of the Senate version, while explaining where there could be compromise on others and where the chamber wasn’t willing to budge.

The plan was to incorporate whatever language is agreed upon into a separate, unrelated legislative vehicle that already cleared both chambers in order to expedite passage. However, even if the bicameral committee were to reach an agreement, the conference report would still need to be approved on the floor of each chamber in order to reach the governor’s desk.

But that did not come to pass as the session ended for the year.

The House passed medical marijuana in the 2021 legislative session & awaits the Senate’s cooperation to bring forward this economic boon & provide relief to ill Kansans. The framework is there; the conference committee must simply meet & pass out legalized #mmj.#ksleg

— Kansas House Democrats (@KSHouseDems) May 23, 2022


Here’s an overview of the key provisions where thebills from the House and Senate already overlapped:

Patients with any of more than 20 qualifying conditions—including cancer, glaucoma, multiple sclerosis, Parkinson’s disease, post-traumatic stress disorder, and autoimmune disorders—would be eligible for medical cannabis.

Patients would be entitled to obtain a 30-day supply of medical cannabis products at a time.

Possession of up to 1.5 ounces of marijuana by a person who isn’t registered as a patient would be decriminalized, punishable by a maximum fine of $400.

Patients’ medical cannabis recommendations would be valid for 90 days, after which point a physician could renew the recommendations for three additional periods. Then extensions could be authorized following a physical examination of the patient annually.

Medical cannabis sales would be subject to the state sales tax of 5.75 percent, with the option of adding a local tax.

Multiple regulatory bodies would be in charge of administering the program. The state Department of Health and Environment, Board of Healing Arts, Board of Pharmacy and a renamed Alcohol and Cannabis Control division would each play a role in the regulations.

The legislation would also establish a medical marijuana advisory committee to help oversee the program and issue recommendations.

The bill calls for five different license types: cultivators, processors, laboratories, distributors and retailers. People would be rendered ineligible for a medical marijuana licenses if they’ve been convicted of a felony, unless that conviction was expunged at least 10 years before the application is submitted.

There would also be a 35 percent THC cap on marijuana plant material.

Counties would be able to enact local bans on permitting marijuana retailers from operating within their jurisdictions through the adopt of a resolution.

With respect to equity provisions, there does not appear to be an explicit pathway for expungements.

Here are some of the changes that the House said it was willing to accept from the Senate bill: 

Pushing back the effective date of the law and deadlines for its implementation.

Removing a 70 percent THC cap on cannabis concentrates.

Out-of-state patients would have reciprocity to both possess and purchase marijuana if they’re registered with their state.

Preventing discrimination in real estate transactions to lease or sell property to registered medical marijuana patients.

Keep the Senate’s licensing application requirements, terms of licensing and rules on where cannabis businesses can operate.

Requiring certain security measures at medical marijuana businesses.

Requiring the state to enter into agreements with tribal governments in order to exchange cannabis.

Doctors wouldn’t have to start “prescribing,” rather than recommending, medical marijuana if the federal government reclassifies cannabis.

Here are some areas where the House insisted on its version, or offered a compromise:

Maintaining most of the list of qualifying conditions for medical marijuana, which includes more than 20 ailments, but keeping its more limited language and removing glaucoma.

Allowing people to receive a medical marijuana business licenses after at least three years of residency in Kansas. The original House bill called for four years, while the Senate had two years.

Allowing regulators to create a unique payment process system for cannabis sales in coordination with the state treasurer.

Keeping a $500 license fee for associated employees of medical marijuana businesses, but lowering fees for other employee types.

Keeping state and local licensing eligibility requirements as stated in the House bill.

There were some additional outstanding items that members hadn’t quite decided on as of last month’s meeting and said they needed additional time to work. Those issues are related to advertising requirements, rules for cultivation facilities, licensing fees, creating a pilot program for medical cannabis and employment discrimination.

After his House counterpart went through the list of provisions and proposals at the April hearing, Olson signaled that members would be going back to leadership to see where the chambers can come to an agreement and then “discuss this at a later date” in conference.

House Minority Leader Tom Sawyer (D) and Assistant Minority Leader Jason Probst (D) said in January that they wanted to let voters decide on legalizing medical and adult-use marijuana in the state.

Gov. Laura Kelly (D), for her part, wants to see medical cannabis legalization enacted, and she said earlier this year that she “absolutely” thinks the bill could pass if “everything else doesn’t take up all the oxygen.”

She previously pushed a separate proposal that would legalize medical cannabis and use the resulting revenue to support Medicaid expansion, with Rep. Brandon Woodard (D) filing the measure on the governor’s behalf.

Kelly has she said she wants voters to put pressure on their representatives to get the reform passed.

The governor also said in 2020 that while she wouldn’t personally advocate for adult-use legalization, she wouldn’t rule out signing the reform into law if a reform bill arrived on her desk.

Top Federal Drug Agency Seeks New Suppliers Of Marijuana For Research

Photo courtesy of Brian Shamblen.

 
 
 

Kansas Democrats are making a final push for the legislature to pass a bill to legalize medical marijuana ahead of Monday’s scheduled end of the session.

While a medical cannabis bill already cleared the House of Representatives last year and a bicameral conference committee met last month to discuss a potential deal to get the measure to the governor’s desk, negotiations appear to have reached a standstill.

If the Republican-controlled legislature doesn’t move quickly, lawmakers will have to start the process all over again in 2023.

“Kansans continue to demand access to medical marijuana. The conference committee on medical marijuana needs to respond; the House is ready to meet and waiting on the Senate’s cooperation,” House Minority Leader Tom Sawyer (D) said in a press release on Friday. “Unless this happens on Monday, May 23rd, the process will restart in the next biennium. Legislators are accountable to constituents and they have made it clear: Legalize medical marijuana. It’s time to listen.”

The #ksleg-islature returns to Topeka on Monday, May 23rd to wrap up the year’s work. There are three things that must be addressed: Providing immediate tax relief, legalizing medical marijuana, and prohibiting gerrymandering.

🧵 Read more: https://t.co/kR1YnFyItw

— Kansas House Democrats (@KSHouseDems) May 20, 2022


Members of the House and Senate Federal and State Affairs Committees held two public meetings last month to discuss a way to merge the House-passed medical marijuana bill with a separate one that Senate lawmakers began considering this year. At the last official meeting, lawmakers from the House side went through areas where they were willing to concede to differences in the other chamber’s bill, as well as provisions they wanted to keep from their own measure.

In general, the two chambers’ proposals were already fairly similar, sharing numerous key provisions.

But to get closer to consensus, House Federal and State Affairs Committee Chairman John Barker (R) said the body is willing to accept about a dozen elements of the Senate version, while explaining where there could be compromise on others and where the chamber wasn’t willing to budge.

—Marijuana Moment is already tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

The plan was to incorporate whatever language is agreed upon into a separate, unrelated legislative vehicle that already cleared both chambers in order to expedite passage. However, even if the bicameral committee were to reach an agreement, the conference report would still need to be approved on the floor of each chamber in order to reach the governor’s desk.

That would need to happen before lawmakers adjourn for the year on Monday.

Kansans continue to demand access to medical marijuana. The conference committee on #mmj needs to respond; the House is ready to meet & waiting on the Senate. Unless this happens on Monday, the process will restart in 2023. #ksleg

— Kansas House Democrats (@KSHouseDems) May 20, 2022


Here’s an overview of the key provisions where thebills from the House and Senate already overlap:

Patients with any of more than 20 qualifying conditions—including cancer, glaucoma, multiple sclerosis, Parkinson’s disease, post-traumatic stress disorder, and autoimmune disorders—would be eligible for medical cannabis.

Patients would be entitled to obtain a 30-day supply of medical cannabis products at a time.

Possession of up to 1.5 ounces of marijuana by a person who isn’t registered as a patient would be decriminalized, punishable by a maximum fine of $400.

Patients’ medical cannabis recommendations would be valid for 90 days, after which point a physician could renew the recommendations for three additional periods. Then extensions could be authorized following a physical examination of the patient annually.

Medical cannabis sales would be subject to the state sales tax of 5.75 percent, with the option of adding a local tax.

Multiple regulatory bodies would be in charge of administering the program. The state Department of Health and Environment, Board of Healing Arts, Board of Pharmacy and a renamed Alcohol and Cannabis Control division would each play a role in the regulations.

The legislation would also establish a medical marijuana advisory committee to help oversee the program and issue recommendations.

The bill calls for five different license types: cultivators, processors, laboratories, distributors and retailers. People would be rendered ineligible for a medical marijuana licenses if they’ve been convicted of a felony, unless that conviction was expunged at least 10 years before the application is submitted.

There would also be a 35 percent THC cap on marijuana plant material.

Counties would be able to enact local bans on permitting marijuana retailers from operating within their jurisdictions through the adopt of a resolution.

With respect to equity provisions, there does not appear to be an explicit pathway for expungements.

💰 The state has the money for tax relief without compromising the budget.

🏥 Medical marijuana is good for the economy & good for Kansans.

❌ Politicians shouldn’t choose their voters. Voters choose their politicians. That’s how democracy works. It’s as simple as that.#ksleg

— Kansas House Democrats (@KSHouseDems) May 22, 2022


Here are some of the changes that the House said it was willing to accept from the Senate bill: 

Pushing back the effective date of the law and deadlines for its implementation.

Removing a 70 percent THC cap on cannabis concentrates.

Out-of-state patients would have reciprocity to both possess and purchase marijuana if they’re registered with their state.

Preventing discrimination in real estate transactions to lease or sell property to registered medical marijuana patients.

Keep the Senate’s licensing application requirements, terms of licensing and rules on where cannabis businesses can operate.

Requiring certain security measures at medical marijuana businesses.

Requiring the state to enter into agreements with tribal governments in order to exchange cannabis.

Doctors wouldn’t have to start “prescribing,” rather than recommending, medical marijuana if the federal government reclassifies cannabis.

Here are some areas where the House is insisting on its version, or offering a compromise:

Maintaining most of the list of qualifying conditions for medical marijuana, which includes more than 20 ailments, but keeping its more limited language and removing glaucoma.

Allowing people to receive a medical marijuana business licenses after at least three years of residency in Kansas. The original House bill called for four years, while the Senate had two years.

Allowing regulators to create a unique payment process system for cannabis sales in coordination with the state treasurer.

Keeping a $500 license fee for associated employees of medical marijuana businesses, but lowering fees for other employee types.

Keeping state and local licensing eligibility requirements as stated in the House bill.

There were some additional outstanding items that members hadn’t quite decided on as of last month’s meeting and said they needed additional time to work. Those issues are related to advertising requirements, rules for cultivation facilities, licensing fees, creating a pilot program for medical cannabis and employment discrimination.

After his House counterpart went through the list of provisions and proposals at the April hearing, Senate Federal and State Affairs Committee Chairman Robert Olson (R) signaled that members would be going back to leadership to see where the chambers can come to an agreement and then “discuss this at a later date” in conference.

It’s not clear how those conversations with leadership have gone, though the conference committee hasn’t since scheduled any additional public meetings to discuss reaching a deal between the two chambers.

Sawyer and Assistant Minority Leader Jason Probst (D) said in January that they wanted to let voters decide on legalizing medical and adult-use marijuana in the state.

Gov. Laura Kelly (D), for her part, wants to see medical cannabis legalization enacted, and she said earlier this year that she “absolutely” thinks the bill could pass if “everything else doesn’t take up all the oxygen.”

She previously pushed a separate proposal that would legalize medical cannabis and use the resulting revenue to support Medicaid expansion, with Rep. Brandon Woodard (D) filing the measure on the governor’s behalf.

Kelly has she said she wants voters to put pressure on their representatives to get the reform passed.

The governor also said in 2020 that while she wouldn’t personally advocate for adult-use legalization, she wouldn’t rule out signing the reform into law if a reform bill arrived on her desk.

More Than 6 In 10 Missouri Adults Support Legalizing Cannabis As Initiative Heads Toward Ballot, New Poll Says

 
 
 

Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page